Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/21/2009EP2110129A1 Use of enantiomer (1S, 2R) milnacipran hydrochloride for the preventive treatment of suicidal behaviour in depressed patients
10/21/2009EP2110128A1 Use of particular antibacterial compounds, which are derived from alliaceae, as natural additives in animal feed
10/21/2009EP2110127A1 Hepatic Fibrosis Inhibitor
10/21/2009EP2110126A1 Inhalative and instillative use of semi-fluorised alkanes as active ingredient carriers in the intrapulmonary area
10/21/2009EP2110125A1 Transdermal drug administration device
10/21/2009EP2110124A1 Bioavailable Solid Dosage Forms of Metaxalone
10/21/2009EP2109618A1 Nitric oxide releasing steroids
10/21/2009EP2109617A1 Nitric oxide releasing steroids
10/21/2009EP2109615A1 Substituted pyrano [2, 3 - b]pyridine derivatives as cannabinoid-1 receptor modulators
10/21/2009EP2109614A1 Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk][1]-benzazepin-2 [1h]-one and zilpaterol
10/21/2009EP2109613A2 Polymorphs of eszopiclone malate
10/21/2009EP2109612A2 5,6,7,8-tetrahydropteridine derivatives as hsp90 inhibitors
10/21/2009EP2109611A1 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
10/21/2009EP2109610A1 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors
10/21/2009EP2109608A1 Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
10/21/2009EP2109607A1 Pyrrolo[3, 2-a]pyridine derivatives for inhibiting ksp kinesin activity
10/21/2009EP2109606A1 Chromene s1p1 receptor antagonist
10/21/2009EP2109605A2 2- [(phenylamino) -pyrimidin-4ylamin0] -cyclopentane carboxamide derivatives and related compounds as inhibitors of kinases of the cell cycle for the treatment of cancer
10/21/2009EP2109604A1 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives
10/21/2009EP2109602A2 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
10/21/2009EP2109600A2 Amorphous and crystalline forms of rivastigmine hydrogentartrate
10/21/2009EP2109462A1 Antitumor combination comprising a morpholinyl anthracycline and an antibody
10/21/2009EP2109454A1 Glp-1 pharmaceutical compositions
10/21/2009EP2109451A1 Encapsulated picoplatin
10/21/2009EP2109450A2 Methods of neuroprotection by cyclin-dependent kinase inhibition
10/21/2009EP2109449A2 Medicament for the treatment of endometriosis
10/21/2009EP2109448A2 Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
10/21/2009EP2109447A1 N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
10/21/2009EP2109440A2 Association of compounds inhibiting melanogenesis and use thereof in cosmetics and dermatology
10/21/2009EP2109363A2 Transport molecules using reverse sequence hiv-tat polypeptides
10/21/2009EP2044046B1 Substituted n-acyl homoserine lactones
10/21/2009EP2041153B1 New 5-thioxylopyranose derivatives
10/21/2009EP2040703B1 Derivatives of 2-benzoyl-imidazopyridines, preparation method thereof and use of same in therapeutics
10/21/2009EP2026771B1 Microspheres comprising nanocapsules containing a lipophilic drug
10/21/2009EP1988909B1 Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing
10/21/2009EP1979320B1 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/21/2009EP1971601B1 N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
10/21/2009EP1904502B1 Antiarrhythmic precursor compounds, methods of synthesis and methods of use
10/21/2009EP1904471B1 Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
10/21/2009EP1853582B1 Heterocyclylamide-substituted imidazoles
10/21/2009EP1838318B1 Use of oxycodone for treating visceral pain
10/21/2009EP1781673B1 Selected fused heterocyclics and uses thereof
10/21/2009EP1781608B1 Indole derivatives comprising an acetylene group as ppar activators
10/21/2009EP1727524B1 Preparation of lipid coated cefuroxime axetil
10/21/2009EP1667666B9 Pharmaceutical composition containing fenofibrate and method for the preparation thereof
10/21/2009EP1608374B9 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/21/2009EP1515724B1 Mitotic kinesin inhibitors
10/21/2009EP1513531B1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
10/21/2009EP1512404B1 External preparations for treating dermatitis
10/21/2009EP1492785B9 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
10/21/2009EP1479300B1 Amino acid powder and process for producing the same
10/21/2009EP1463506B1 Substituted quinazoline derivatives as inhibitors of aurora kinases
10/21/2009EP1450811B1 Compounds specific to adenosine A1 and A3 receptors and uses thereof
10/21/2009EP1450750B1 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
10/21/2009EP1448526B1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
10/21/2009EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors
10/21/2009EP1381366B9 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/21/2009EP1346993B1 Lactam compounds and medical use thereof
10/21/2009EP1322624B1 Arylalkane-sulfonamides having endothelin-antagonist activity
10/21/2009EP1311238B1 Use of di-sugar alcohol phosphates to protect human skin cells from uv-and/or ir radiation
10/21/2009EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
10/21/2009EP1207877B1 Anti-inflammatory actions of cytochrome p450 epoxygenase-derived eicosanoids
10/21/2009EP1187598B1 Micropigment mixture
10/21/2009EP1169462B1 Oil comprising brassicastanol
10/21/2009EP1169062B1 Heat stable coated colloidal iron oxides
10/21/2009EP1166766B1 External preparation compositions
10/21/2009EP1164991B1 Gels formed by the interaction of poly(aldehyde) with various substances
10/21/2009EP1162968B1 Epigallocatechin-gallate for inhibiting angiogenesis
10/21/2009EP1117672B1 Antisense modulation of survivin expression
10/21/2009EP1047784B1 Neissera meningitidis antigens
10/21/2009EP1047436B1 N-acetylhomotaurinates for use in treating hyperkinesias
10/21/2009EP0986372B1 Vesicular complexes and methods of making and using the same
10/21/2009EP0900200B9 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
10/21/2009EP0716615B2 Low flux transdermal potent drug delivery system
10/21/2009CN101563353A Antibacterial compounds and processes for its production
10/21/2009CN101563352A Antiviral indoles
10/21/2009CN101563351A Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
10/21/2009CN101563350A Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5-a]pyrimidin-7-yl]-phenyl-N-methyl-acetamide
10/21/2009CN101563349A Haloalkyl-substituted pyrimidinone derivatives
10/21/2009CN101563345A Pharmaceutical compounds
10/21/2009CN101563344A Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/21/2009CN101563343A Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/21/2009CN101563342A Imidazolidinonyl aminopyrimidine compounds for the treatment' of cancer
10/21/2009CN101563341A Piperidine derivative used for treating chemokine receptor 5 mediated diseases
10/21/2009CN101563340A 2-benzimidaz0lyl-6-m0rph0lin0-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
10/21/2009CN101563339A 2 -benzimidazolyl- 6 -morpholino-4- (azetidine, pyrrolidine, piperidine or azepine) pyrimidine derivatives as PI3K and MTOR inhibitors for the treatment of proliferative disorders
10/21/2009CN101563338A MAPK/ERK kinase inhibitors
10/21/2009CN101563336A Heterocyclic organic compounds for the treatment of in particular melanoma
10/21/2009CN101563332A Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments
10/21/2009CN101563330A Benzoyl amino heterocyclyl compounds as glucokinase (GLK) activators
10/21/2009CN101563328A Substituted heteroaryl pyridopyrimidone derivatives
10/21/2009CN101563327A Pyrimidine kinase inhibitors
10/21/2009CN101563324A Spiro-piperidine derivatives
10/21/2009CN101563323A Spiro-piperidine derivatives
10/21/2009CN101563322A 1H-indole-2-carboxylic acid derivatives useful as PPAR modulators
10/21/2009CN101563321A 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands
10/21/2009CN101563320A [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
10/21/2009CN101563318A N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain
10/21/2009CN101563317A O-substituted-dibenzyl urea-derivatives as TRPV1 receptor antagonists
10/21/2009CN101563218A Laminates of acid polysaccharide films
1 ... 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 ... 7860